| Key Dates | |
|---|---|
|
Clinical Trials in Progress Submission Site Opens |
November 13 |
|
P2s Submission Site Opens |
January 7 |
| Clinical Trials in Progress Submission Deadline | February 3, 11:59 p.m. EST |
| P2s Submission Deadline | February 16, 11:59 p.m. EST |
Clinical Trials in Progress
About the Program
Clinical Trials in Progress sessions are designed to increase awareness of important clinical trials that are either ongoing or in the late design phase. These trials should not be completed, and there is no expectation that data will be presented. Accepted abstracts will describe studies that are expected to substantially influence practice when they are ultimately reported and/or published.
Trials that are accepted will be featured in the Learning Lab, which showcases engaging presentations at AUA2026. This venue will be adjacent to the Science & Technology Hall and attracts a robust attendance.
P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology
About the Program
Practice-changing, Paradigm-shifting Clinical Trials in Urology (P2s) are designed to showcase exceptional, groundbreaking studies that are expected to change the day-to-day practice of urology. Reserved for the most impactful studies, P2s will be presented on the Plenary stage, providing the greatest exposure and profile for the research. Results should not have been presented previously at any other meeting.
Abstracts
The AUA is no longer accepting abstracts for the 2026 Annual Meeting. Acceptance notifications will go out in January 2026.